Tedros Adhanom Ghebreyesus, Director General of the World Health Organization (WHO) speaks after Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases through the 148th session of the Executive Board on the coronavirus illness (COVID-19) outbreak in Geneva, Switzerland, January 21, 2021.
Christopher Black | WHO | by way of Reuters
The World Health Organization mentioned Friday it’s reviewing current reports of blood clots in some people who acquired the AstraZeneca Covid-19 vaccine which have prompted just a few nations to halt their rollout of the photographs.
At least 9 nations, together with Denmark, Norway, Iceland and Thailand, have suspended their use of the vaccine over security issues. As of Wednesday, round 5 million people in Europe had acquired the Oxford-AstraZeneca vaccine. Of this determine, 30 so-called thromboembolic occasions have been reported in recipients. Those are blood clots that type in blood vessels and block blood stream.
AstraZeneca mentioned in an announcement Friday that there is “no evidence” that the vaccine causes an elevated threat of creating blood clots.
WHO Director-General Tedros Adhanom Ghebreyesus mentioned Friday that the company’s Global Advisory Committee on Vaccine Safety “systematically reviews safety signals and is carefully assessing the current reports on the AstraZeneca vaccine.”
“As soon as WHO has gained the full understanding of these events,” he added, “the findings and any changes to our current recommendations will be communicated immediately to the public.”
Dr. Mariangela Simao, WHO assistant director-general for entry to medicines and well being merchandise, added that the worldwide well being company will “probably have a statement on this next week as investigations are completed.”
“WHO is very much aligned with the position that we should continue immunization until we have clarified the causal relationship,” she mentioned.
Dr. Soumya Swaminathan, WHO’s chief scientist, mentioned it stays unclear if the vaccine is definitely inflicting the blood clots. An AstraZeneca spokesperson famous that “the observed number of these types of events are significantly lower in those vaccinated than what would be expected among the general population.”
“The adverse events which are reported after vaccination have to be seen in the context of events which occur naturally in the population,” Swaminathan mentioned. “Just because it’s reported following a vaccination doesn’t mean that it’s because of the vaccination. It could be completely unrelated.”
Europe’s drug regulator, the European Medicines Agency, has confused that there isn’t any indication the AstraZeneca shot is inflicting blood clots, including it believes the vaccine’s advantages “continue to outweigh its risks.”
“Reports of blood clots received so far are not greater than the number that would have occurred naturally in the vaccinated population,” mentioned Dr. Phil Bryan, vaccines security lead at Britain’s Medicines and Healthcare Products Regulatory Agency.
“The safety of the public will always come first. We are keeping this issue under close review but available evidence does not confirm that the vaccine is the cause. People should still go and get their COVID-19 vaccine when asked to do so,” he added.
— CNBC’s Sam Meredith contributed to this report.